FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

20358311000001104: Amorolfine 5% medicated nail lacquer (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68772401000001116 Amorolfine 5% medicated nail lacquer (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
68772501000001117 Amorolfine 5% medicated nail lacquer (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Is a Amorolfine 5% medicated nail lacquer true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Is a Amorolfine 5% medicated nail lacquer false Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Is a Amorolfine 5% nail lacquer false Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has active ingredient Amorolfine true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has specific active ingredient Amorolfine hydrochloride true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amorolfine true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has dispensed dose form Medicated nail laquer false Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has basis of strength substance Amorolfine true Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has dispensed dose form Medicated nail lacquer false Inferred relationship Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Has dispensed dose form Medicated nail lacquer true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Amorolfine 5% medicated nail lacquer (Teva UK Ltd) 5 ml Has AMP True Amorolfine 5% medicated nail lacquer (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start